How can an obstetrician (OB) determine if a fetus has a small stomach and what are the associated concerns?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Determining Fetal Stomach Size and Associated Concerns

An obstetrician determines if a fetus has a small stomach through transabdominal ultrasound measurement of stomach dimensions (longitudinal, anteroposterior, and transverse diameters), comparing these measurements to gestational age-specific nomograms, with a small or absent stomach after 18 weeks gestation carrying a 52-85% risk of abnormal outcome including structural abnormalities, chromosomal anomalies, and fetal/neonatal death. 1, 2

How to Determine Small Fetal Stomach

Ultrasound Assessment Method

  • Transabdominal ultrasound is the primary imaging modality for evaluating fetal stomach size, performed as part of the detailed fetal anatomic examination. 3

  • Measure three stomach dimensions: longitudinal, anteroposterior, and transverse diameters using real-time high-resolution ultrasound. 2

  • Compare measurements to gestational age-specific nomograms: Normal fetal stomach shows linear growth throughout pregnancy with high correlation between gestational age and all three diameters (r = 0.749-0.809). 2

  • The stomach is considered abnormal if: the stomach bubble is absent or remains very small and unchanged for at least 45 minutes during sonographic examination after 14 weeks gestation. 4

Timing Considerations

  • Evaluate after 18 weeks gestation: A small or absent stomach before this time may be less clinically significant. 1

  • Serial examinations are critical: A single non-visualization may be transient, but repeat imaging should occur to confirm persistent findings. 4

  • Detailed anatomic survey should be performed at 18-22 weeks as part of routine screening, with the stomach being one of the required structures to visualize. 3

Clinical Concerns and Prognosis

Overall Outcomes

  • Absent stomach carries 85% risk of abnormal outcome including structural abnormalities, intrauterine fetal death, or postnatal death. 1

  • Small stomach carries 52% risk of abnormal outcome, significantly better than absent stomach but still concerning. 1

  • Combined risk is 63% when either finding is present after 18 weeks gestation. 1

Specific Associated Abnormalities

Chromosomal Anomalies:

  • 38% of fetuses with absent stomach have abnormal karyotype. 1
  • 4% of fetuses with small stomach have abnormal karyotype. 1
  • Diagnostic testing with chromosomal microarray analysis should be offered when fetal growth restriction is detected with malformations or when unexplained isolated growth restriction is diagnosed before 32 weeks. 3

Structural Abnormalities:

  • Gastrointestinal anomalies including esophageal atresia, tracheoesophageal fistula, duodenal atresia, and gastroschisis are common associations. 3, 1
  • Central nervous system anomalies may coexist, requiring detailed neurologic assessment. 3
  • Approximately 10% of fetuses with growth restriction have congenital anomalies. 3

Amniotic Fluid Abnormalities:

  • 88% abnormal outcome when oligohydramnios is present with non-visualized stomach. 4
  • 100% abnormal outcome when polyhydramnios is present with non-visualized stomach. 4
  • Amniotic fluid volume assessment is critical in all cases of suspected stomach abnormalities. 3

Important Clinical Pitfalls

Transient Findings:

  • Not all transient non-visualizations are benign: 25% of cases where the stomach normalized on subsequent scans still had abnormal outcomes including persistent postnatal disability. 4
  • Serial imaging is mandatory even when initial follow-up shows normal stomach. 4

Isolated Findings:

  • 48% of cases have non-visualization as the only abnormal finding, yet 20% of these still have abnormal outcomes. 1, 4
  • Do not be falsely reassured by absence of other anomalies on initial scan. 4

Additional Abnormalities:

  • 88% abnormal outcome when other sonographic abnormalities are present alongside stomach findings. 4
  • Detailed anatomic survey is essential to identify associated malformations. 3

Management Algorithm

Initial Detection of Small/Absent Stomach

  1. Confirm finding with extended observation (minimum 45 minutes) to exclude transient non-filling. 4

  2. Perform detailed fetal anatomic examination (CPT 76811) to identify associated structural abnormalities. 3

  3. Assess amniotic fluid volume as this significantly impacts prognosis. 3, 4

  4. Evaluate for fetal growth restriction using estimated fetal weight and abdominal circumference measurements. 3

Diagnostic Workup

  • Offer genetic testing with chromosomal microarray analysis, especially if detected before 32 weeks or if other abnormalities are present. 3

  • Consider fetal MRI if ultrasound findings are incomplete or additional anatomic detail is needed, ideally performed at or after 22 weeks gestation. 3

  • Screen for cytomegalovirus via amniocentesis PCR in unexplained cases. 3

Surveillance Strategy

  • Serial ultrasound examinations every 2-4 weeks to monitor stomach size, growth parameters, and amniotic fluid. 3

  • Umbilical artery Doppler assessment if growth restriction is confirmed. 3

  • Biophysical profile testing after viability to assess fetal well-being. 3

References

Research

Growth of the fetal stomach in normal pregnancies.

Obstetrics and gynecology, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.